Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cellular therapies for unmet medical needs, today announced additional patient data from its ongoing Phase I/IIa clinical study of OpRegen®, the Company’s retinal pigment epithelium (RPE) transplant therapy, for the treatment of dry age-related macular degeneration (dry AMD), a leading cause of adult blindness in the developed world with no FDA-approved treatment options.

Integrated care teams and care management tools led to 3,600 fewer bed days in a year

Merry & Bright - Brainwave Christmas Illuminations and Surprises Friends Visiting with Brainwave Illumination

Minimally Invasive Spiration® Valve System Now Recommended as Part of Standard of Care for Treatment of Severe Emphysema by International Clinical Guidelines

Add Teaser here

Novel Drug Delivery Technology Strengthens Targeted Oncologic Therapy Approach

Trial of Voclosporin Meets All Primary and Secondary Endpoints with Clean Safety Profile

Landmark study reports greater success with minimally invasive vascular access procedure

NYC Surgical Associates, a leading multi-specialty surgical practice with five locations across the New York Metro area, is pioneering a unique approach to treating overactive bladders through a simple corrective procedure to relieve pressure from blood pooling in the veins surrounding the bladder, a condition that can cause urinary frequency issues. While other treatment measures such as drugs and Botox can have unwanted side effects, this minimally-invasive procedure has been shown to yield a 95% success rate with total symptom resolution.

Study in Nature Sheds New Light on Heart Treatment Controversy

Innovative external urine collection device improves quality of care and reduce facility costs

The US Pain Collaborative, comprised of advocacy leaders from across the pain community, today announced the publication of a report, titled "Chronic Pain Assessment: Patient Perspectives."

Four real-world studies presented at the Annual Liver Meeting of the American Association for the Study of Liver Diseases

The phase 3 trial (KALM-1) completion of the drug difelikefalin (CR845) shows results of improved itch-related quality of life for patients undergoing dialysis treatment

Hospitals are inherently noisy environments, with staff members discussing medical details with one another, machines beeping constantly, and the rolling of chairs or stretching across tile floors.

A large new study has found that an artery disease that mostly affects legs and feet is associated with increased use of opioids, the Society for Vascular Surgery reports.

Health communication program, supported by Amgen Oncology since 2009, has evolved with innovative tools, including virtual healthcare provider tool in English and Spanish

Analysis of more than 4,300 adverse events reveals bifurcated healthcare system challenging patient outcomes

Data from pivotal study demonstrate safety and efficacy regardless of prior gastrectomy in previously treated patients with metastatic gastric cancer (mGC) and gastroesophageal junction (GEJ) adenocarcinoma

Data from Prospective, Observational Study will Strengthen Clinical Evidence and Support Continued Cologuard Adoption